| Q92375760 | 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial |
| Q90245576 | 3D-printed automation for optimized PET radiochemistry |
| Q90140874 | 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer |
| Q90111595 | 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer |
| Q64080488 | Detection Efficacy of F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy |
| Q92643925 | Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer |
| Q57171336 | Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications |
| Q96128360 | Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET |
| Q61805756 | Initial evaluation of PET/CT with F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients |
| Q64054352 | Intra-individual comparison of Ga-PSMA-11 and F-DCFPyL normal-organ biodistribution |
| Q90310413 | Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings |
| Q58593270 | Nonspecific Uptake of Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature |
| Q58107966 | PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics |
| Q52589267 | Potential impact of 68Ga-PSMA-11 PET/CT on prostate cancer definitive radiation therapy planning. |
| Q90264578 | Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer |
| Q92268924 | Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer |
| Q89882344 | Prostate Cancer Nodal Staging: Using Deep Learning to Predict 68Ga-PSMA-Positivity from CT Imaging Alone |
| Q90196812 | Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines |
| Q93002364 | [68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up? |
| Q92235800 | qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT |